IFN therapy results in an improvement of survival rates of patients with C-viral chronic hepatitis and liver cirrhosis.

被引：0
|
作者：
Ohshiro, S [1 ]
Moriyama, M [1 ]
Higuchi, A [1 ]
Nasuno, K [1 ]
Matsumura, H [1 ]
Goto, I [1 ]
Tanaka, N [1 ]
Arakawa, Y [1 ]
机构：
[1] Nihon Univ, Sch Med, Tokyo, Japan
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
810
引用
收藏
页码：362A / 362A
页数：1
相关论文
共 50 条
  • [1] Factors influencing the progression or liver fibrosis in C-viral chronic hepatitis and liver cirrhosis.
    Kaneko, M
    Moriyama, M
    Matsumura, H
    Aoki, H
    Goto, I
    Tanaka, N
    Arakawa, Y
    [J]. HEPATOLOGY, 2000, 32 (04) : 540A - 540A
  • [2] Interferon therapy results in an improvement in the life expectancy of patients with type C chronic hepatitis and liver cirrhosis.
    Matsumura, H
    Moriyama, M
    Aoki, H
    Shimizu, T
    Kaneko, M
    Shioda, A
    Goto, I
    Tanaka, N
    Arakawa, Y
    [J]. HEPATOLOGY, 2002, 36 (04) : 357A - 357A
  • [3] Interferon therapy improves the irregular regeneration of hepatocytes in liver in patients with C-viral chronic hepatitis and liver cirrhosis
    Moriyama, Mitsuhiko
    Matsumura, Hiroshi
    Oshiro, Shu
    Nakamura, Hitomi
    Arakawa, Yasuo
    Nirei, Kazushige
    Aoki, Hiroshi
    Yamagami, Hiroaki
    Kaneko, Miki
    Tanaka, Naohide
    Arakawa, Yasuyuki
    [J]. INTERVIROLOGY, 2007, 50 (02) : 138 - 149
  • [4] IFN prevents the progression of liver cirrhosis and prolongs survival in compensated chronic hepatitis C and cirrhosis.
    Nishiguchi, S
    Nakatani, S
    Minamitani, S
    Fukuda, K
    Tamori, A
    Takeda, T
    Shiomi, S
    Seki, S
    Kuroki, T
    [J]. HEPATOLOGY, 1998, 28 (04) : 698A - 698A
  • [5] Occult HBV infection influence the long-term outcome in patients with C-viral chronic hepatitis or liver cirrhosis
    Yasuo, Arakawa
    Moriyama, Mitsuhiko
    Yasuyuki, Arakawa
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A848 - A848
  • [6] Upregulation of leptin in liver tissue of patients with viral hepatitis and cirrhosis.
    Kaul, A
    Jandl, O
    Mix, H
    Flemming, P
    Widjaja, A
    Manns, MP
    Wagner, S
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A911 - A911
  • [7] Randomized trial of effects of IFN-alpha on incidence of hepatocellular carcinoma and survival rate of patients with chronic active hepatitis C and cirrhosis.
    Nakatani, S
    Nishiguchi, S
    Takeda, T
    Nakajima, S
    Shiomi, S
    Seki, S
    Kuroki, T
    Kobayashi, K
    Monna, T
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1274 - A1274
  • [8] The effect of successful anti-viral therapy on health-related quality of life for patients with chronic hepatitis C and cirrhosis.
    Cooksley, G
    Foster, G
    Green, J
    Kleinman, L
    Hakim, Z
    Revicki, D
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A951 - A951
  • [9] Suppression of hepatitis B virus replication by lamiduvine results in improvement of liver function in patients with severe cirrhosis.
    Villeneuve, JP
    Bilodeau, M
    Fenyves, D
    Pomier, G
    Pilon, D
    Raymond, G
    Willems, B
    [J]. HEPATOLOGY, 1997, 26 (04) : 1205 - 1205
  • [10] Living donor liver transplantation to patients with hepatitis C virus cirrhosis.
    Sugawara, Yasuhiko
    Makuuchi, Masatoshi
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (28) : 4461 - 4465
12345